Fig. 3.
The clinical course of the five patients who received DMARDs without pre-emptive therapy. None of them developed HBV reactivation. a Patient 5. b Patient 6. c Patient 7. d Patient 8. e Patient 9
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.